. (1975). Annals of the Rheumatic Diseases, 34, 213-218. Naturally occurring anti-inflammatory factors in the synovial fluids of patients with rheumatic disease and their possible mode of action. (1) Evidence has been shown that pathological synovial fluid contained a substance capable of stabilizing rat liver lysosomes which was partly inactivated by treatment with trypsin and by storage. Such synovial fluid also appeared to contain a substance which labilized lysosomes and which was more stable than the stabilizing substance. (2) The lysosomal stabilizing substance described above was nondialysable and migrated electrophoretically with the a and fP globulins to which class it has been tentatively ascribed. (3) Pathological synovial fluid contained proteases which were active at acid pH and at neutral pH. It also appeared to contain a substance capable of inhibiting these proteases. (4) a2-Macroglobulin has been detected in pathogenic synovial fluid.
It is well established that inflammatory exudates in animal models contain substances that inhibit inflammation (Billingham, Robinson, and Robson, 1969a, b; Di Pasquale, Girerd, Beach, and Steinetz, 1963) . Since these substances are accompanied by irritants present in the exudates (Atkinson, Boura, and Hicks, 1969) , it appears that the net inflammatory condition is the result of the opposing interaction of the two types of factor. Billingham and Robinson (1972) have recently isolated an anti-inflammatory protein fraction from carrageenin-induced inflammatory exudate in rats and shown that this fraction was devoid of significant irritant properties. The mode of action of these anti-inflammatory proteins is not known.
In this report we have examined the synovial fluids of patients with rheumatic disease for naturally occurring anti-inflammatory factors. In particular, we have looked for evidence of antiproteases and membrane active substances as indications in vitro of anti-inflammatory activity.
Antiproteases
Lysosomal enzymes, at least in part, are thought to be responsible for the degradation of the cartilage matrix in rheumatoid arthritis (Dingle, 1962) . The presence of specific antiproteases, such as antitrypsin, in serum has been established for some time, but recently Barrett and Starkey (1973) have produced evidence that a2-macroglobulin may act as a universal antiprotease. It is well established in animal models that inflammation is accompanied by raised proteolysis and that an induction of protease inhibitors takes place during inflammation (Menkin, 1942; Ungar, 1947) . It was also established that these inhibitors can modify the inflammatory response.
Membrane active substances Luscombe (1963) and other authors have reported that lysosomal enzyme levels are raised in the synovial fluids of patients with rheumatoid arthritis. It is well established that corticosteroids and some nonsteroidal anti-inflammatory drugs stabilize lysosomes.
This action has been proposed to explain at least part of the anti-inflammatory action of these drugs. There is evidence that endogenous proteins can also stabilize lysosomes in vivo (Persellin, 1972) . Using the arthritic rat as a model, Collins and Lewis (1971) showed that after the administration of the adjuvant, serum lysosomal enzyme levels rose rapidly to abnormally high values. Subsequently these enzyme levels fell to normal but rose again with the onset of inflammation. Ignarro and Slywka (1972) showed that the initial rise of lysosomal enzyme levels was due to an increased fragility of liver lysosomes. However, Persellin (1972) has shown that this initial fragility is later abolished by the formation in vivo of a circulating high molecular weight a-globulin with an affinity for lysosomal and erythrocyte membranes. This globulin was not an antibody and was absent from control animals.
Purpose of present study The objects of the experiments reported in this paper were: (1) To investigate the possibility that endogenous inflammatory and anti-inflammatory factors are present in the synovial fluids of patients with rheumatic disease. (2) To investigate the nature of these factors, if present, and to determine their possible mode of action.
Materials and methods

SYNOVIAL FLUIDS AND CELLS
These were obtained from patients at the Royal National Hospital for Rheumatic Diseases, Bath, and the cells isolated from the fluids as previously described (Lewis and Day, 1972) . The fluids and cells were examined as soon as possible after aspiration but where storage was necessary this was at 4°C, and cell-free fluids after ultracentrifugation were stored at -20°C.
ACTION OF SYNOVIAL FLUIDS ON ISOLATED RAT LIVER LYSOSOMES
The rat liver lysosomes were isolated by methods previously described (Lewis, Symons, and Ancill, 1969) and suspended in tris-acetate buffered isotonic sucrose (pH 7 4). The final protein concentration ofthe suspension was adjusted to 5 mg/ml (Lowry, Rosebrough, Farr, and Randall, 1951) . In a typical incubation 3 ml of the suspension was incubated with 1 ml of synovial fluid and the volume made up to 5 ml with buffered sucrose. The mixtures so prepared were incubated for 90 min at 37°C in a shaking reaction incubator followed by ultracentrifugation at 20000 g for 30 min to remove the lysosomes. Acid phosphatase (E.C. 3.1.3.2) activity in the supematant was used as a marker and assayed by the method of Symons and others (1969) . In the controls, synovial fluid was omitted from some flasks and lysosomes from others. In other experiments, synovial fluids were pretreated by incubation with an equal volume of 5 % w/v trypsin for 60 min at 37°C. Two ml of the hydrolysate were then added to 3 ml of the lysosomal suspension and the effect of the hydrolysed fluid on the stability of the lysosomes determined as described above. In some flasks the synovial fluid was replaced by buffer in order that the direct action of trypsin on lysosomes could be determined.
SEPARATION OF PROTEINS FROM SYNOVIAL FLUID
Two methods were employed. Chemical separation An equal volume of saturated ammonium sulphate solution was added to synovial fluid at 4°C. The solution was stirred and allowed to stand for an hour in a refrigerator. The precipitated protein (the globulin fraction) was then removed by centrifugation. The clear supernatant was then saturated with ammonium sulphate and allowed to stand for a further hour, to precipitate the albumin fraction, and was then centrifuged again. Both fractions were separately dialysed against tris buffered sucrose (pH 7 4).
Chromatographic separation
Synovial fluid was applied to the top of a column packed with Sephadex G200 after the void volume had been determined with Dextran Blue 2000. The column was eluted with tris-acetate buffer solution (pH 7 4) and the fractions collected automatically. The separation was performed at 4°C. The fractions were assayed for protein at 280 nm and pooled into three main fractions containing (in order of elution) a and ,B globulins, globulins, and albumins. The proteins present in each fraction were identified by electrophoresis in cellulose acetate strips. Each fraction prepared by both methods described above was concentrated to small bulk by dehydration in dialysis sacs placed in Aquacide (Calbiochem) at 4°C. The protein concentration of each solution was determined by the method of Lowry and others (1951) .
ELECTROPHORESIS AND IMMUNOELECTROPHORESIS OF SYNOVIAL FLUID
Attempts to separate synovial fluid proteins on cellulose acetate strips were largely unsuccessful owing to streaking. This problem was overcome by using agar gel films on microscope slides. Wells and slots were cut with a pattern cutter (Shandon) and the slides were developed at 2mA/cm in a 0-1 mol/l acetate-barbiturate buffer adjusted to pH 8f6 with HCI. Bromophenol blue was used as a marker. After development, the slides were dried with filter paper and immersed for 60 min in a 1 % w/v solution of Amido Black in 7% w/v acetic acid and washed in 7 % acetic acid until the background was clear. In the immunoelectrophoretic studies the antisera were placed in the slots and the plates allowed to stand overnight in a humidity cabinet (Shandon). The plates were then washed in saline and the precipitin lines stained with Amido Black as described above.
PREPARATION OF ANTISERA Rabbit antisera were prepared against human synovial fluid and against rat liver lysosomal membranes that had been previously treated with human synovial fluid.* The rat liver lysosomes were incubated with synovial fluid as described above and then isolated from the suspension by ultracentrifugation. The lysosomes were washed in a large excess of saline and isolated twice to freezing and thawing and then suspended in a large excess of saline. The membranes were obtained by further ultracentrifugation.
Both the membrane preparations and the synovial fluid were emulsified with arachis oil. Two ml of the emulsions were injected into the footpads of rabbits and at various intramuscular sites. The treatment was repeated a month later and blood samples taken from an ear vein after a further two weeks. The blood was allowed to clot and the serum removed by decanting.
*Rabbit antisera against human a2-macroglobulin were purchased from Mercia Diagnostics Ltd.,watford, Herts.
PROTEASE DETERMINATIONS IN SYNOVIAL FLUIDS
Acid protease activity was assayed at pH 4-0 by the method of Anson (1938) and neutral protease at pH 7-8 using Hide Powder Azure (Calbiochem) as substrate by the method of Rinderknecht, Geokas, Silverman, Lillard, and Haverback (1968) . In order to examine the synovial fluids for antiprotease action against acid protease, synovial fluid cells were removed from the fluids by centrifugation and lysed by freezing and thawing in the appropriate buffer solution. In the samples taken at least 90% of the cell types were polymorphonuclear leucocytes. The acid protease activities ofthe lysates were determined. In some experiments equal volumes of synovial fluid were added to the cell lysate and the protease activity determined. The cell suspension was omitted from the controls.
Results
ACTION OF SYNOVIAL FLUID ON LYSOSOMES
From Table I it will be seen that the results were different for different patients. Clearly opposing effects were observed in that some of the fluids had an irritant action on lysosomes and others had a stabilizing action. The effect of trypsin-treated synovial fluid on lysosomes is shown in Table II . Trypsin undoubtedly causes lysis of the lysosomes but trypsin and synovial fluid combined had a stronger lytic action than the sum of trypsin and synovial fluid separately. One possible explanation for this effect is that pretreatment of the synovial fluid with trypsin has destroyed protective substances originally present in the fluids. Some evidence for this view is provided by the results in Table I . The stabilizing action of samples 14, 15, and 16 was far greater when the fluid was fresh than when the samples were 6 months old, although stored deep frozen. It appears that over the 6 months some destruction of the lysosomal membrane stabilizing factor has occurred, possibly by autoproteolysis.
Dialysis of the synovial fluid before incubation with lysosomes did not abolish or reduce the stabilizing action of the fluid. These results are given in Table III . Where the proteins were isolated from synovial fluid by ammonium sulphate precipitation, the globulin fraction has had a greater stabilizing action than the albumin fraction. A similar result was obtained when the proteins were separated by gel filtration. This experiment showed that the stabilizing action of the proteins was largely confined to the high molecular weight proteins (the a and a1 globulin fraction). The y globulin fraction and the albumin fraction had little stabilizing action.
ELECTROPHORESIS AND IMMUNOELECTRO-PHORESIS OF SYNOVIAL FLUID PROTEINS
The pattern obtained on staining agar plates with Amido Black is shown in Figure a . The precipitin pattern obtained when the plates were treated with rabbit antisera against human synovial fluid is shown in Figure b . When the plates were treated with rabbit antisera against rat liver lysosomes that had been treated with human synovial fluid two precipitin lines were obtained (Figure c ). Clearly proteins in the a and ,B globulin class had associated with the rat liver lysosomes. No evidence was obtained for y-globulins being associated with the lysosomal membranes and this result is consistent with the results obtained when the gel filtration protein fractions were incubated with lysosomes. The presence of a2-macroglobulin was detected in blood and in some synovial fluids but was absent in others (see Table I ). Barrett and Starkey (1973) with serum suggests that a2-macroglobulin may be a universal antiprotease. Further work is in progress in our laboratory in an attempt to identify the specific proteins, present in synovial fluid, responsible for the anti-inflammatory mechanisms we have reported. One such protein has been identified. Using rabbit antiserum to human a2-macroglobulin; a2-macroglobulin has been identified in some pathogenic synovial fluids.
In this communication we have reported the presence of two naturally occurring factors in pathological knee effusions whose biochemical properties suggest that they could be anti-inflammatory. It is as yet unknown how the levels of these factors may vary with the course of inflammatory disease and whether the severity of disease can be directly related to the concentrations of these factors. Work is in progress in an attempt to resolve these problems.
